- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06148779
Can Digitally Delivered First-line Osteoarthritis Treatment Improve Equal Access to Care (Access)
Can Digitally Delivered First-line Osteoarthritis Treatment Improve Equal Access to Care in Urban and Rural Areas of Sweden
Study Overview
Status
Detailed Description
Since 2008 Sweden has had a structured first-line face-to-face knee and hip osteoarthritis (OA) treatment program, Better management of patients with OsteoArthritis (BOA). However, records show that this face-to-face program is underutilized and reaches only a minority of those that would benefit from it.
The first-line OA management program has been transformed into a digital version, Joint Academy® (JA), to facilitate implementation, scaling, increased accessibility, and improved patient adherence. The mobile application (app) consists of video instructions distributed daily with individualized exercises for participants with knee or hip OA, as well as educational information on OA symptoms and self-management based on current international guidelines for the management of OA. Each participant is assigned to a physical therapist available through asynchronous chat and telephone who supervises the participant throughout the whole program.
To improve chronically ill patients' health and quality of life, long-standing and continuous treatment is needed at an acceptable cost. Recent evidence suggests that JA costs 25% compared to the BOA program for three months of treatment. Providing patients with equal access to care necessitates availability in urban and rural areas alike. This can potentially be achieved by digital delivery, but it is yet unknown if digital delivery of first-line OA treatment, compared with face-to-face, improves equal access to care. The purpose of this study was to compare utilization of digital and face-to-face delivered OA treatment in the 21 different county councils of Sweden that are responsible for providing healthcare to the residents.
Method Registered patient participation in the BOA program during 2021-2023 will be retrieved from the BOA Register. The BOA registry. Data from digital program participation was retrieved from the JA database. To be included, a patient need to have registered for the first visit in the BOA registry or have enrolled in the program by answering the first questionnaire in the JA registry.
Population density per county and county size were retrieved from Statistics Sweden. Results were calculated and presented as users per 100 000 residents. Mean and median values as well as standard deviations were calculated separately for registered participants/100 000 for BOA and JA programs, and for regions with more (n=12) or less (n=8) than 20 residents per km2.
Please not that the BOA registry was in January 2023 renamed to The Swedish Osteoarthritis Registry.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Håkan Nero, Med dr
- Phone Number: +46406550292
- Email: hakan@jointacademy.com
Study Contact Backup
- Name: Leif E Dahlberg, Senior professor
- Phone Number: +46406550292
- Email: leif@jointacademy.com
Study Locations
-
-
-
Malmö, Sweden
- Recruiting
- Joint Academy
-
Contact:
- Leif E Dahlberg, Senior Professor
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Participants with knee or hip OA that have joined the digital OA treatment program via online advertisements and campaigns placed on search engines and social networks, or by recommendations by their local physiotherapist or orthopaedic surgeon. Procedure for inclusion and exclusion has been described above.
Data will be extracted from the Joint Academy (JA) database and the Better management of patients with OsteoArthritis (BOA) registry.
Description
* Patients in the Joint Academy database that had participated in the Joint Academy treatment program for OA and given their informed consent to participate in research.
Inclusion criteria for the treatment program:
- Radiographic and or clinical diagnosis of hip or knee OA from a physical therapist or physician (95% of all patients in previously published studies). Individuals without a prior diagnosis had clinical OA confirmed by an orthopaedic surgeon or physiotherapist via telephone (diagnosis according to National Institute for Health and Care Excellence (NICE) criteria and Swedish National Guidelines, and confirming the absence of any red flag symptoms), or if deemed necessary were recommended to seek face-to-face care before inclusion in the programme.
- From October 1st 2021, all patients should have undergone a physical examination by doctor or physiotherapists before being able to enter the treatment.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Joint Academy
|
Digitally delivered first-line for osteoarthritis through the caregiver Joint Academy.
|
|
BOA
|
First-line for osteoarthritis delivered at a primary care clinic face-to-face with reported data to the BOA registry.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postal code/Official Municipality Key
Time Frame: Baseline
|
Postal code/Official Municipality Key of participants
|
Baseline
|
|
Postal code/Official Municipality Key for primary care center
Time Frame: Baseline
|
For the BOA group only
|
Baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Leif E Dahlberg, Senior professor, Joint Academy
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Access to care OA
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis
-
Hacettepe UniversityNot yet recruitingThumb Osteoarthritis | Trapeziometacarpal Osteoarthritis | Carpometacarpal Osteoarthritis | Thumb Basal Joint OsteoarthritisTurkey (Türkiye)
-
Sanford HealthTerminatedKnee Osteoarthritis | Hip Osteoarthritis | Shoulder Osteoarthritis | Ankle Osteoarthritis | Wrist OsteoarthritisUnited States
-
Edin MešanovićCompletedOsteoarthritis | Osteoarthritis of the Knee | Osteoarthritis of Knee | Osteoarthritis of the Knees | Osteoarthritis (OA) of the Knee | Osteoarthritis Knee | Osteoarthritis in the Knee | Osteoarthritis of Knee JointBosnia and Herzegovina
-
Hospital for Special Surgery, New YorkRoyal Infirmary of EdinburghRecruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder OsteoarthritisUnited States, United Kingdom
-
Middlesex UniversityRecruitingOsteoarthritis | Osteoarthritis (OA) | Osteoarthritis (OA) of the Knee | Osteoarthritis (OA) of the HipUnited Kingdom
-
Golden Jubilee National HospitalJohnson & Johnson; DePuy OrthopaedicsNot yet recruitingOsteoarthritis | Knee Osteoarthritis | Osteoarthritis (OA) | Osteo Arthritis | Osteoarthritis in the Knee | Osteoarthritis (Knee) | Osteo Arthritis of the KneeUnited Kingdom
-
University of EdinburghHospital for Special Surgery, New YorkActive, not recruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder OsteoarthritisUnited Kingdom
-
Medical University of WarsawUnknownOsteoarthritis | Knee Osteoarthritis | Hip Osteoarthritis | Glenohumeral OsteoarthritisPoland
-
Medical University of WarsawUnknownOsteoarthritis | Knee Osteoarthritis | Hip Osteoarthritis | Glenohumeral OsteoarthritisPoland
-
Istanbul University - CerrahpasaCompletedKnee Osteoarthritis | Knee Osteoarthritis (Knee OA)Turkey (Türkiye)
Clinical Trials on Digitally delivered first-line treatment for osteoarthritis
-
Lund UniversityCompletedKnee Osteoarthritis | Hip OsteoarthritisSweden
-
Joint AcademyLund UniversityCompleted
-
Region StockholmKarolinska InstitutetCompleted
-
Joint AcademyLund UniversityCompletedShoulder Pain | Subacromial Pain SyndromeSweden
-
Joint AcademyLund UniversityCompletedPain | Physical FunctionSweden
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityNot yet recruitingRadiotherapy | Metastatic Gastric Carcinoma | Immune Checkpoint TherapyChina
-
Peking University First HospitalBeijing Chao Yang Hospital; Beijing Anzhen HospitalNot yet recruitingLight Chain (AL) Amyloidosis | MRDChina
-
Tuen Mun HospitalUnknownWeight Loss | Chemotherapy Effect | Prognosis | Cancer, ColorectalHong Kong
-
Henan Cancer HospitalRecruitingNSCLC | Brain Metastases | Leptomeningeal MetastasisChina
-
CHU de ReimsUnknown